Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
The COX-2 inhibitor SC-236 exerts anti-inflammatory effects by suppressing phosphorylation of ERK in a murine model
InChiKey: PLVGDGRBPMVYPB-FDUHJNRSSA-N
PubMed PMID: 31773093
and complicated intra-abdominal or urinary-tract infections
3Z)-3-(hydroxyimino)-2'-oxo-1'
Belinostat (PXD101) Catalog No.:M22445-C The COX-2 inhibitor SC-236 exertsBelinostat (also known as PXD101) is a novel and potent hydroxamate type inhibitor of histone deacetylase (HDAC) that inhibits the activity of HDAC in Hela cell extracts with 50% inhibition concentration IC50 value of 27 nM. Belinostat has been found to significantly increase the acetylation of histones H3 and H4 and exerts cytotoxicity in a wide range of tumor cell lines. In the treatment of urothelial carcinoma cell lines, belinostat dose
US$ 10.86
US$ 16.42
US$ 10.19
US$ 12.03